uMed Platform

The uMed platform automates the process of identifying, engaging, and consenting targeted cohorts for clinical studies and registries. uMed has the unique capability to combine health records, ePRO, and biomarker and genomics samples collected from the patient at home. uMed brings paid studies from life science organizations and other researchers to the heath system. No grants or RFP forms to fill out.

The uMed Platform is deployed within the provider environment which ensures that data never leave without the permission of the health system and consent of the patient. All outreach through the uMed platform is done on behalf of the patient's recognized provider.

The uMed platform uses clinical data extracts from the health system so EMR integrations are not required. The platform is free to the health system, and the health system may use the platform for its own or other 3rd party studies.

The uMed platform is therapy and study agnostic. The uMed platform may be utilized for multiple purposes across a range of study activities, including those related to pediatrics.

uMed provides the platform to healthcare providers and life science organizations.

The uMed platform provides several benefits over existing internal solutions:

1) The uMed platform can identify study cohorts for the studies uMed brings to the health system, as well as internally-generated or 3rd party research studies. This capability greatly reduces the demands and burden on IT.

2) Once a study is approved, the uMed platform automatically engages patients via SMS or email, all on behalf of their recognized provider. The health system doesn't have to staff a team of nurses or enrollment specialists to "smile and dial" in order to notify, enroll, and consent patients into the study. It is all done automatically, through the uMed platform.

3) The uMed platform allows for the remote collection of ePRO as well as biomarker and 'omic samples. This frees up time for internal staff, frees up clinic space for other uses, and makes it easier for the patient to participate in studies without having to go to a physical location.